Based upon our clinical research results, we have standardized the p53 gene test and optimized it for routine clinical application. With the aid of this MARK53 analysis, it is now possible to determine the p53 gene status of practically every tumor material. The result enables conclusions to be drawn on the expected efficacy of a chemotherapy and radiotherapy.
For the first time, in the form of the MARK53® analysis, a p53 gene test is available that is standardized, maximally precise and nevertheless easy to use, and that has also been clinically tested. This test thus meets the standards of routine clinical application!
Further information on the MARK53® analysis can be found under: www.mark53.com. You can request and order our p53 gene test via this Internet site.